Navigation Links
Pricing and Reimbursement Strategies for Medical Devices
Date:3/20/2012

NEW YORK, March 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Pricing and Reimbursement Strategies for Medical Devices

http://www.reportlinker.com/p0799254/Pricing-and-Reimbursement-Strategies-for-Medical-Devices.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Facility

 

The routes to medical devices being purchased within public healthcare systems vary significantly between countries. The major markets of the US and Europe are examined in this report, analyzing the strategies being used by medical device manufacturers to sell and succeed within them.Understand the healthcare structure in the US, Germany, France, Italy, Spain, and the UK.Identify the most prominent factors influencing the reimbursement environment globally and on a country-specific basis.Gain insight into the reimbursement routes for three product sectors in each country.Compare the differences in pricing and market entry strategies that work best in each country.Gain recommendations for how pricing and reimbursement strategies should be developed for optimum results.

Diagnosis related groupings (DRGs) are taking in an ever-increasing role in the payment processes applied to medical devices. DRGs are becoming more refined and top-up payments are being rationalized.

In the US, price skimming is the most frequently used strategy in the medical device market, but market segmentation should be used to assess if other strategies, such as penetration pricing, would be more apt in particular sectors.

Within each country regional differences between purchasing and pricing are increasing. Pricing should be determined by examining the requirements of the purchasing institution and regional requirements, but caution should be taken not to undervalue the product and to be aware of the global strategy. It is easier to lower a price than to raise it.

What is the nature of the market environment across Europe and in the US?How are the reimbursement sectors divided?Who pays for medical devices and what are the decision-making processes involved?What role do national health frameworks play, and which government bodies have the greatest influence on pricing and reimbursement?What is appropriate pricing, and how is the correct balance achieved?

 

 

 

About the author

Disclaimer

EXECUTIVE SUMMARY

An overview of pricing

An overview of reimbursement

Pricing and reimbursement in the US

An overview of Europe

France

Germany

Italy

Spain

The UK

Conclusions for global pricing and market access strategies

An overview of pricing

Summary

Introduction

Pricing and value

Pricing strategies

Price sensitivity

Methods of assessing price sensitivity

Economy pricing

Price skimming

Penetration pricing

Pre-emptive pricing

Extinction pricing

Premium or prestige pricing

Cost-based pricing

Cost-plus pricing

Experience-curve pricing

Pricing differentiation

Competitive parity

Market segmentation

The realities of pricing strategies

An overview of reimbursement

Summary

Introduction

Reimbursement mechanisms

The importance of classification

The importance of health technology assessment

Pricing and reimbursement in the US

Summary

Introduction

Market environment

Medicaid

Procurement

Reimbursement and coding

Key pricing and market access issues

FDA and CMS considerations

Distribution

An overview of Europe

Summary

Introduction

Procurement

Reimbursement and coding

France

Summary

Introduction

Market environment

Procurement

Reimbursement and coding

Capital equipment

Non-capital equipment

Ambulatory

Key pricing and market access issues

Strategies

Company examples

Useful addresses

Germany

Summary

Introduction

Market environment

Procurement

Reimbursement and coding

Capital equipment

Non-capital equipment

Ambulatory

Key pricing and market access issues

Strategies

Company examples

Addresses

Italy

Summary

Introduction

Market environment

Hospital corporations

USL-managed public hospitals

Agreed private clinics

Procurement

Reimbursement and coding

Capital equipment

Non-capital equipment

Agreed private clinics

Key pricing and market access issues

Strategies

Company examples

Addresses

Spain

Summary

Introduction

Market environment

Procurement

Reimbursement and coding

Capital equipment

Non-capital equipment

Private clinics

Key pricing and market access issues

Strategies

Company examples

Addresses

The UK

Summary

Introduction

Market environment

Procurement

Reimbursement and coding

Non-capital equipment

Private clinics

Key pricing and market access issues

Strategies

Company examples

Addresses

Conclusions for global pricing and market access strategies

Summary

Introduction

Local optimization

Global coordination

Appendix

Scope

Methodology

Primary research

Secondary research

Glossary/Abbreviations

References

 

 

Companies mentioned

Aalberts Industries N.V., ERGO Versicherungsgruppe AG, Groupama S.A., Hutchison 3G UK Limited, Imperial Tobacco Group PLC, Informa plc, Johnson & Johnson, Kaiser Permanente, McKesson Corporation, Metro AG, Publicis Groupe SA, Schindler Holding Ltd., Siemens Healthcare, Sistema JSFC

 

To order this report:

Medical Facility Industry: Pricing and Reimbursement Strategies for Medical Devices

More Market Research Report

Check our Industry Analysis and Insights

 

 

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ChemoCentryx Announces Pricing of Initial Public Offering
2. Cempra, Inc. Announces Pricing of Its Initial Public Offering of Common Stock
3. CVS Caremark Corporation Settles FTC Deceptive Pricing Charges
4. Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing
5. UHC Launches RxLINK™, Gives Hospitals Unprecedented Insight Into Pharmaceutical Pricing
6. Watson Wins Kentucky Drug Pricing Litigation
7. Unilife Corporation Announces Pricing of Offering of 8,250,000 Shares of Common Stock
8. Pacira Pharmaceuticals, Inc. Announces Pricing of Follow-On Offering
9. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
10. Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering
11. Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... LA JOLLA, Calif. , Feb. 23, 2017 /PRNewswire/ ... biopharmaceutical company leading the discovery and development of innovative ... quarter and full year 2016 financial results on Thursday, ... Regulus will host a conference call and webcast on ... discuss fourth quarter and full year 2016 financial results ...
(Date:2/23/2017)... -- According to a new market research ... Analog), MRI (Closed, Open), Ultrasound, CT, Nuclear Imaging (SPECT, ... (Hospitals, Imaging Centers) - Global Forecast to 2021", published ... the forecast period of 2016 to 2021. The market ... at a CAGR of 6.6% from 2016 to 2021. ...
(Date:2/23/2017)... Feb 23, 2017 ... Research and Markets has announced the addition of ... to 2025" report to their offering. The Global ... 1.8% over the next decade to reach approximately $12.8 billion by 2025. ... forecasts for all the given segments on global as well as regional ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management Association will ... at the annual Building Better Radiology Marketing Programs conference, held this year ... Worth, Texas. Nine awards are given out in five categories. They are:, ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
(Date:2/23/2017)... ... 23, 2017 , ... The 89th Academy Awards will be celebrated this weekend, ... Policy Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” ... is the Center for American Progress (CAP), for its report, Lessons From State Performance ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
Breaking Medicine News(10 mins):